CD4 and inflammatory bowel disease: Therefore, the aim of this study was to assess whether baseline circulating CD4+ and CD8+ α4β7+ memory T cell subpopulations, several lymphocytic markers previously involved in the physiopathology of IBD (19, 20), and their changes during treatment could be predictors of response to VDZ in patients with UC.